Company profilePharmaceutical#885 of 1,318 in Pakistan✓ No DRAP alerts

SERVIER RESEARCH & PHARMACEUTICALS PAKISTAN (PVT) LTD.

Pharmaceutical company · 6 brands · 8 molecules

Ranked #39 of 70 companies in Cardiac Care

6 registered products 10 pharmaceutical brands 8 distinct molecules 0 DRAP alerts

Company overview

6
registered products
10
pharmaceutical brands
8
distinct molecules
3
therapeutic classes
0
DRAP alerts

SERVIER RESEARCH & PHARMACEUTICALS PAKISTAN (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 6 product registrations across 8 distinct molecules. Its portfolio is concentrated in Cardiac Care and Ace Inhibitor. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SERVIER

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Therapeutic classes

Cardiac Care · 2Ace Inhibitor · 2Psychostimulants, Nootropic & Neurotonic · 1

Conditions treated

Hypertension · 2

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO9 products · Rs 330 – Rs 926.6
Servaid7 products · Rs 183.1 – Rs 401.8
Median across source: Rs 674.1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Servier Pharma holds 12 molecules not in this portfolio
AmlodipineDiosminGliclazideHesperidinIndapamideIvabradine
CSH Pharmaceuticals (Pvt.) Ltd., holds 9 molecules not in this portfolio
AmoxicillinAmpicillinAmpicillin.....CefiximeCeftriaxoneCeftriaxone Sodium
Atco Pharma International (Pvt) Ltd holds 232 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for SERVIER

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.